Join
Live feed
·
INSIDERFilingvia Quantisnow
Abeona Therapeutics Inc. logo

Director Alvino Mark sold $35,463 worth of shares (6,500 units at $5.46), decreasing direct ownership by 8% to 77,565 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABEO· Abeona Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.) and more on Quantisnow.